Rankings
▼
Calendar
CERS Q3 2020 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena
CERS
Cerus Corporation
$335M
Q3 2020 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$24M
+31.0% YoY
Gross Profit
$13M
53.6% margin
Operating Income
-$14M
-59.2% margin
Net Income
-$14M
-59.9% margin
EPS (Diluted)
$-0.08
QoQ Revenue Growth
+9.8%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$213M
Total Liabilities
$104M
Stockholders' Equity
$109M
Cash & Equivalents
$29M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$18M
+31.0%
Gross Profit
$13M
$10M
+21.3%
Operating Income
-$14M
-$17M
+17.5%
Net Income
-$14M
-$18M
+21.3%
Revenue Segments
Government Contract
$6M
100%
Geographic Segments
Europe Middle East And Africa
$15M
62%
North America
$8M
36%
Other
$615,000
3%
← FY 2020
All Quarters
Q4 2020 →